drugset / Trial / NCT05279560

Ovarian PRP (Platelet Rich Plasma) Injection for Follicular Activation

NCT05279560

Active not recruiting 114 enrolled University of Luebeck
RandomizedParallel-groupSingle-blindTreatment

Summary

The primary objective is to investigate the efficacy, defined as an increase in oocyte numbers upon ovarian stimulation, and safety of a single intra-ovarian PRP injection vs. saline solution (NaCl) injection (Placebo) transvaginally or laparoscopically for follicular activation in patients with child wish and with low ovarian reserve/expected poor ovarian response planning to undergo IVF or ICSI using own eggs. Pain score as numerical rating score and validated quality of life questionnaire will be requested after the procedure. Longterm follow-up of all participants will be performed 1, 2 and 5 years after end of study.

Timeline

Start
2022-03-17
Primary completion
2025-04-30
Completion
2030-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified 5 ml Other